Wearable Exercise Trackers in Cancer Rehabilitation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03042884 |
Recruitment Status :
Completed
First Posted : February 3, 2017
Last Update Posted : December 17, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The goal of this research study is to learn how useful a wearable exercise tracker watch is to monitor your physical activity.
This is an investigational study.
Up to 100 participants will be enrolled in this study. All will take part at MD Anderson.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Benign Neoplasms In Situ Neoplasms Malignant Neoplasms of Independent (Primary) Multiple Sites | Behavioral: Questionnaires Device: Wearable Exercise Tracker Watch | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 111 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Wearable Exercise Trackers in Cancer Rehabilitation |
Actual Study Start Date : | February 13, 2017 |
Actual Primary Completion Date : | December 14, 2020 |
Actual Study Completion Date : | December 14, 2020 |

Arm | Intervention/treatment |
---|---|
Experimental: Wearable Exercise Trackers - Inpatient Group
Questionnaires completed at baseline and within 24 hours of discharge. Participant given a wearable exercise tracker to be worn 24 hours a day while in the acute inpatient rehabilitation unit. |
Behavioral: Questionnaires
Inpatient Group: Participants complete a questionnaire about any symptoms they may have had in the past 24 hours. The questionnaire should take about 5 minutes to complete. Within 24 hours of being discharged, same questionnaire about symptoms and a questionnaire about experience with the wearable exercise tracker. These questionnaires should take about 10 minutes total to complete. Outpatient Group: Participants complete 2 questionnaires about any symptoms they may have had in the past 24 hours and their current level of physical function. These should take about 10 minutes total to complete. At the end of the 14-day period, participant called by the study staff to remind them to complete the same 2 questionnaires about symptoms and level of physical function. Participants complete another questionnaire about their experience with the wearable exercise tracker. These questionnaires should take about 15 minutes total to complete. Other Name: Surveys Device: Wearable Exercise Tracker Watch Inpatient Group: Participants receive a wearable exercise tracker watch upon admission to acute inpatient rehabilitation unit. Participant to wear the exercise tracker watch on their wrist for 24 hours a day. Device to be returned within 24 hours before being discharged. Outpatient Group: Participants receive a wearable exercise tracker watch to wear on their wrist for 24 hours a day for 14 days. Device to be returned at next visit. |
Experimental: Wearable Exercise Trackers - Outpatient Group
Questionnaires completed at baseline and again in 14 days. Participant given a wearable exercise tracker to be worn 24 hours a day for 14 days. |
Behavioral: Questionnaires
Inpatient Group: Participants complete a questionnaire about any symptoms they may have had in the past 24 hours. The questionnaire should take about 5 minutes to complete. Within 24 hours of being discharged, same questionnaire about symptoms and a questionnaire about experience with the wearable exercise tracker. These questionnaires should take about 10 minutes total to complete. Outpatient Group: Participants complete 2 questionnaires about any symptoms they may have had in the past 24 hours and their current level of physical function. These should take about 10 minutes total to complete. At the end of the 14-day period, participant called by the study staff to remind them to complete the same 2 questionnaires about symptoms and level of physical function. Participants complete another questionnaire about their experience with the wearable exercise tracker. These questionnaires should take about 15 minutes total to complete. Other Name: Surveys Device: Wearable Exercise Tracker Watch Inpatient Group: Participants receive a wearable exercise tracker watch upon admission to acute inpatient rehabilitation unit. Participant to wear the exercise tracker watch on their wrist for 24 hours a day. Device to be returned within 24 hours before being discharged. Outpatient Group: Participants receive a wearable exercise tracker watch to wear on their wrist for 24 hours a day for 14 days. Device to be returned at next visit. |
- Usefulness of Exercise Tracker in Acute Inpatient Rehabilitation Unit Per Edmonton Symptom Assessment Scale (ESAS-FS) [ Time Frame: 14 days ]Exercise tracker considered useful if at least 2/3 patients consider it as useful.
- Usefulness of Exercise Tracker as an Outpatient Per Edmonton Symptom Assessment Scale (ESAS-FS) [ Time Frame: 14 days ]Exercise tracker considered useful if at least 2/3 patients consider it as useful.
- Usefulness of Exercise Tracker in Acute Inpatient Rehabilitation Unit Per Patient Reported Outcomes Measurement Information System (PROMIS) [ Time Frame: 14 days ]Exercise tracker considered useful if at least 2/3 patients consider it as useful.
- Usefulness of Exercise Tracker as an Outpatient Per Patient Reported Outcomes Measurement Information System (PROMIS) [ Time Frame: 14 days ]Exercise tracker considered useful if at least 2/3 patients consider it as useful.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Men and women with literacy as demonstrated by reading and signing informed consent form
- At least 18 years of age, since the rehabilitation unit and physical medicine and rehabilitation clinic is open to patients 18 years of age or older
- Patients admitted to the acute inpatient rehabilitation unit and those seen in the Physical Medicine and Rehabilitation outpatient clinic
- Capable of completing questionnaire in English
Exclusion Criteria:
1) Patients currently using a wearable activity tracker

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03042884
United States, Texas | |
University of Texas MD Anderson Cancer Center | |
Houston, Texas, United States, 77030 |
Principal Investigator: | Amy Ng, MD | M.D. Anderson Cancer Center |
Responsible Party: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT03042884 |
Other Study ID Numbers: |
2016-0671 |
First Posted: | February 3, 2017 Key Record Dates |
Last Update Posted: | December 17, 2020 |
Last Verified: | December 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Benign Neoplasms In Situ Neoplasms Malignant Neoplasms of Independent (Primary) Multiple Sites |
Wearable exercise trackers Questionnaires Surveys |
Neoplasms |